This paper examines the strategic incentive for gene holders to vertically integrate with seed companies, and with herbicide/insecticide oligopolies, given the unique institutional structure and relevant market in agricultural biotechnology. We model the case with homogeneous basic seeds, and investigate both pre-entry and post-entry equilibrium.